Ephedrine hydrochloride - AAH Pharmaceuticals Ltd
AAH Pharmaceuticals
Description
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days
Indications
For the management of reversible airways obstruction.
Ephedrine is less suitable and less safe for use as a bronchodilator than the selective beta2 agonists, because it is more likely to cause arrhythmias and other side-effects. It should be avoided if possible.
Contraindications
Avoid use in the case of renal impairment, pregnancy and breast feeding.
Preparations Available
Tablet, solution for injection
Sizes Available
Tablets
15 mg, pack of 28
30 mg, pack of 28
Injection ampoules
30 mg/10 ml, 10 ampoules
30 mg/1 ml, 10 ampoules
More on: Bronchodilators , Other adrenoceptor agonists